111 Capital’s Labcorp LH Stock Holding History

111 Capital’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$529K	Buy	+1,888	New	+$496K	0.09%	227
2025 Q2	–	Sell	-1,685	Closed	-$392K	–	613
2025 Q1	$392K	Buy	+1,685	New	+$409K	0.08%	267

Other funds holding LH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

111 Capital's LH Position: Q2 2026 in Review

111 Capital opened a new position in Labcorp (LH) in Q2 2026: 1,888 shares worth $529K. The stake represents 0.09% of the portfolio and ranks #227 among its holdings. This is a return to the name: 111 Capital previously reported a position in LH as recently as Q1 2025.

111 Capital first reported a position in LH in Q1 2025 and has held it in 2 quarters since. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

111 Capital held 1,888 shares of Labcorp worth $529K as of Q2 2026.
Labcorp was a new 111 Capital position in Q2 2026.
Labcorp made up 0.09% of 111 Capital's portfolio in Q2 2026, its #227 holding.
111 Capital first reported a position in Labcorp in Q1 2025 and has held it in 2 quarters since.
1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on 111 Capital's 13F filing for Q2 2026, filed 5 Aug 2026.